Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Operating Expenses | 469 | 775 | 1,179 | 1,473 | 821 |
| Operating Income | -469 | -775 | -1,179 | -1,473 | -821 |
| Other Income | 2 | 4 | 7 | 5 | 6 |
| Pre-tax Income | -467 | -772 | -1,173 | -1,467 | -815 |
| Net Income Continuous | -467 | -772 | -1,173 | -1,467 | -815 |
| Net Income | $-467 | $-772 | $-1,173 | $-1,467 | $-815 |
| EPS Basic Total Ops | -0.24 | -0.18 | -0.28 | -0.37 | -0.28 |
| EPS Basic Continuous Ops | -0.13 | -0.21 | -0.32 | -0.40 | -0.30 |
| EPS Diluted Total Ops | -0.24 | -0.18 | -0.28 | -0.37 | -0.28 |
| EPS Diluted Continuous Ops | -0.13 | -0.21 | -0.32 | -0.40 | -0.30 |
| EBITDA(a) | $-469 | $-775 | $-1,179 | $-1,473 | $-821 |